Argus: Anthrax Vaccine Maker Emergent BioSolutions Poised For Earnings Growth
Emergent Biosolutions Inc (NYSE: EBS), a maker of vaccines and products for infectious diseases as well as chemical, biological or nuclear attacks, picked up a sell-side bull Wednesday. Latest Ratings for EBS Da.....»»
Emergent"s stock falls 6.8% after error making J&J"s COVID-19 vaccine
Shares of Emergent BioSolutions Inc. were down 6.8% in premarket trading on Thursday, the day after Johnson & Johnson confirmed that a batch of its COVID-19 vaccines manufactured at an Emergent plant did not meet "quality standards." Th.....»»
New York Times Credits Report On Emergent BioSolutions For Biden"s Canceled Vaccine Plant Visit
The New York Times (NYSE: NYT) is crediting its reporting for President Joe Biden’s decision to cancel a visit to a coronavirus vaccine plant operated by Emergent BioSolutions read more.....»»
Invisalign maker Align Technologies spikes 15% after revenue and earnings beat estimates
Align reported $834.5 million in revenue during the fourth quarter, notching 28% year-over-year growth and beating analyst estimates by $40 million. An Invisalign installation procedure, Align's flags.....»»
Lululemon sees earnings growth at "high end" of expectations, but stock falls
Lululemon Athletica Inc. said Monday it now expects year-over-year growth in fiscal fourth-quarter adjusted earnings per share and revenue to be at the "high end" of its previous guidance ranges. The yoga gear maker ha.....»»
Mark Hulbert: Earnings momentum strategies made big money but are now losing the big mo’
Value stocks look poised to outperform growth rivals in 2021......»»
Optical filter maker Apogee reports strong earnings for 1Q20
Active/passive optical filter maker Apogee Optocom has reported robust earnings growth for the first quarter of 2020, bolstered by increased shipments of its passive optical filters and an improvement of its products mix, according to company sources......»»
Emergent Biosolutions CEO on Trump"s wishes to develop a vaccine by year end — "Nobody can guarantee anything"
"We're here ... doing everything we can to make sure that a vaccine and treatments are available as soon as possible," CEO Robert Kramer said......»»
Emergent BioSolutions CEO: We"re here to support vaccine candidates
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
COVID-19 vaccine developer takes key step toward coronavirus trial in early summer
Vaxart Inc. will work with Emergent BioSolutions Inc. to develop and make the Peninsula company's oral vaccine candidate against the potentially deadly COVID-19 coronavirus. The move is an important step for a small South San Francisco company hoping.....»»
Vaxart enters pact with Emergent BioSolutions to develop COVID-19 vaccine
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent BioSolutions, Vertex partner to develop oral COVID-19 vaccine
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent BioSolutions CEO Talks Coronavirus Vaccine Development
Global life sciences company Emergent Biosolutions Inc (NYSE: EBS) CEO Bob Kramer said Thursday that his company's partnership with read more.....»»
PepsiCo profit inches past estimate as it increases dividend by 7%
PepsiCo reported a sharp decline in fourth-quarter profit as the beverage and snack maker forecast earnings growth for 2020. PepsiCo said fourth-quarter net income fell to $1.77 billion, or $1.26 a share, from $6.85 billion, or $4......»»
Emergent BioSolutions: EMA approves plan for CHIKV VLP vaccine candidate
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hasbro upgraded on earnings growth potential from Entertainment One acquisition
Hasbro Inc. shares rose 3.4% in Monday trading after the toy maker was upgraded to buy from neutral at UBS based on the earnings growth potential from the Enterta.....»»
Emergent BioSolutions announces five-year growth strategy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2019 Results - Earnings Call Transcript
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2019 Results - Earnings Call Transcript.....»»
Analysts Say Additional Fastenal Upside Is Limited Following Earnings Pop
Fastenal Company (NASDAQ: FAST) shares jumped 17.2% to a new all-time high on Friday after the company reported earnings and revenue beats. The construction equipment maker reported 7.8% sales growth, while gross margins dropped fr.....»»
Emergent BioSolutions" chikungunya vaccine receives EMA prime designation
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»